These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 19580287)
21. In Vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Sentürk M; Gülçin I; Beydemir S; Küfrevioğlu Oİ; Supuran CT Chem Biol Drug Des; 2011 Jun; 77(6):494-9. PubMed ID: 21332948 [TBL] [Abstract][Full Text] [Related]
22. A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies. Alp C; Ekinci D; Gültekin MS; Sentürk M; Sahin E; Küfrevioğlu OI Bioorg Med Chem; 2010 Jun; 18(12):4468-74. PubMed ID: 20554206 [TBL] [Abstract][Full Text] [Related]
23. NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II. Ekinci D; Cavdar H; Talaz O; Sentürk M; Supuran CT Bioorg Med Chem; 2010 May; 18(10):3559-63. PubMed ID: 20430631 [TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates. Nuti E; Orlandini E; Nencetti S; Rossello A; Innocenti A; Scozzafava A; Supuran CT Bioorg Med Chem; 2007 Mar; 15(6):2298-311. PubMed ID: 17276072 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterisation of two novel proton transfer compounds and their inhibition studies on carbonic anhydrase isoenzymes. Yenikaya C; Sari M; Bülbül M; Ilkimen H; Cinar B; Büyükgüngör O J Enzyme Inhib Med Chem; 2011 Feb; 26(1):104-14. PubMed ID: 20860527 [TBL] [Abstract][Full Text] [Related]
26. Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis. Poulsen SA; Bornaghi LF Bioorg Med Chem; 2006 May; 14(10):3275-84. PubMed ID: 16431113 [TBL] [Abstract][Full Text] [Related]
27. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides. Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776 [TBL] [Abstract][Full Text] [Related]
29. Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I. Temperini C; Innocenti A; Guerri A; Scozzafava A; Rusconi S; Supuran CT Bioorg Med Chem Lett; 2007 Apr; 17(8):2210-5. PubMed ID: 17314045 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel bromophenol derivatives as carbonic anhydrase inhibitors. Akbaba Y; Balaydın HT; Menzek A; Göksu S; Şahin E; Ekinci D Arch Pharm (Weinheim); 2013 Jun; 346(6):447-54. PubMed ID: 23649517 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Yenikaya C; Sari M; Bülbül M; Ilkimen H; Celik H; Büyükgüngör O Bioorg Med Chem; 2010 Jan; 18(2):930-8. PubMed ID: 20006931 [TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Temperini C; Cecchi A; Scozzafava A; Supuran CT Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014 [TBL] [Abstract][Full Text] [Related]
33. Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II. Banerjee AL; Tobwala S; Ganguly B; Mallik S; Srivastava DK Biochemistry; 2005 Mar; 44(10):3673-82. PubMed ID: 15751944 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of carbonic anhydrase isozymes I and II with natural products extracted from plants, mushrooms and honey. Sahin H; Can Z; Yildiz O; Kolayli S; Innocenti A; Scozzafava G; Supuran CT J Enzyme Inhib Med Chem; 2012 Jun; 27(3):395-402. PubMed ID: 21740099 [TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors. Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663 [TBL] [Abstract][Full Text] [Related]
36. Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Akıncıoğlu A; Topal M; Gülçin I; Göksu S Arch Pharm (Weinheim); 2014 Jan; 347(1):68-76. PubMed ID: 24243403 [TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes. Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076 [TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881 [TBL] [Abstract][Full Text] [Related]
39. Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors. Erzengin M; Bilen C; Ergun A; Gencer N Arch Physiol Biochem; 2014 Feb; 120(1):29-33. PubMed ID: 24289818 [TBL] [Abstract][Full Text] [Related]
40. Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds. Iyer R; Barrese AA; Parakh S; Parker CN; Tripp BC J Biomol Screen; 2006 Oct; 11(7):782-91. PubMed ID: 16858005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]